Velarion Records
Free. Unsubscribe any time.

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

ARROWHEAD PHARMACEUTICALS, INC. filed 23 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 62 transactions and 740,162 shares. None carries the SEC's AFF10B5ONE flag; all 23 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in ARROWHEAD PHARMACEUTICALS, INC. 62

Adoption dates in ARROWHEAD PHARMACEUTICALS, INC. 0

Results prints in ARROWHEAD PHARMACEUTICALS, INC. 7

Trades before a print in ARROWHEAD PHARMACEUTICALS, INC. 0

Interval to ARROWHEAD PHARMACEUTICALS, INC.’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.